Childhood maltreatment has been linked with chronic pain in adulthood, primarily through retrospective studies. Our ongoing longitudinal study in women with and without a history of documented childhood maltreatment (CM), the Female Adolescent Development Study (FADS), was leveraged to comprehensively and prospectively examine pain characteristics in a subset of adult women. Twenty-nine women (Mage=28.24, SD=1.19) with (n=15) and without (n=14) a history of CM completed surveys assessing the number of pain locations (widespread pain index, WPI) and severity of somatic symptoms (SS) over the past 3-months, the Graded Chronic Pain Scale (GCPS) to assess pain intensity and interference over the past 6-months, and the Comprehensive Trauma Interview to assess interpersonal violence exposure in adulthood (IPVA). Independent samples t-tests were conducted to compare pain outcomes (WPI; SS; WPI + SS for a Total Symptom Score; and GCPS) between participants with and without a history of CM. We also explored the impact of IPVA on outcomes. Women with a history of CM reported more pain locations (MWPI=2.20 vs. 1.71, d=.19), greater symptom severity (MSS=5.67 vs. 3.86, Cohen's d=.60), and greater Total Symptom Scores (M=7.87 vs. 5.57, d=.49). Pain intensity and pain interference on the GCPS were also higher for women with a CM history (Mintensity=45.95 vs. 30.00, d=.64; Minterference=35.24 vs. 29.52, d=.19). Most women who experienced CM also experienced IPVA. Comparisons between those who experienced IPVA versus those who did not yield similar results to that of CM, with more robust effect sizes. Preliminary results suggest that women with a history of CM are at greater risk for chronic pain, pain interference, and higher severity of somatic symptoms in adulthood. This risk may be amplified among those who have experienced both CM and IPVA. The underlying mechanisms by which adversity influences risk for chronic pain needs further study. Supported by Cincinnati Children's Research Innovation/Pilot Funding Program - Grant number: RIP_020821-020722.